Giant cell arteritis: controversial issues
Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that c...
Gespeichert in:
Veröffentlicht in: | Vnitřní lékar̆stvĭ 2021-07, Vol.67 (4), p.224-229 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | cze ; eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 229 |
---|---|
container_issue | 4 |
container_start_page | 224 |
container_title | Vnitřní lékar̆stvĭ |
container_volume | 67 |
creator | Alušík, Štefan |
description | Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment. |
doi_str_mv | 10.36290/vnl.2021.057 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2553246400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2553246400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c948-f0268c1974cdaa91f41adafc7904cd1499b531a20d5ff12b50dc5b06f60dd4e43</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhoMottQevcoeRdg6-d54E9EqFLz04C1k8wGR7W5NtgX_vamtzuWF4eGd4UHoGsOCCqLgft93CwIEL4DLMzTFDeBackXO0RSAkVpK-jFB85w_oYxQgku4RBPKiOQUmim6W0bTj5X1XVeZNPoUx5gfKjv0Yxr2PuVouirmvPP5Cl0E02U_P-UMrV-e10-v9ep9-fb0uKqtYk0dgIjGYiWZdcYoHBg2zgQrFZQNZkq1nGJDwPEQMGk5OMtbEEGAc8wzOkO3x9ptGr7K2VFvYj78Z3o_7LImnFPCBAMoaH1EbRpyTj7obYobk741Bv0rSBdB-iBIF0GFvzlV79qNd__0nw76Ax--YEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2553246400</pqid></control><display><type>article</type><title>Giant cell arteritis: controversial issues</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Alušík, Štefan</creator><creatorcontrib>Alušík, Štefan</creatorcontrib><description>Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.</description><identifier>ISSN: 0042-773X</identifier><identifier>EISSN: 1801-7592</identifier><identifier>DOI: 10.36290/vnl.2021.057</identifier><identifier>PMID: 34275308</identifier><language>cze ; eng</language><publisher>Czech Republic</publisher><subject>Biopsy ; Giant Cell Arteritis - diagnosis ; Giant Cell Arteritis - drug therapy ; Glucocorticoids - therapeutic use ; Humans ; Inflammation ; Male ; Temporal Arteries</subject><ispartof>Vnitřní lékar̆stvĭ, 2021-07, Vol.67 (4), p.224-229</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c948-f0268c1974cdaa91f41adafc7904cd1499b531a20d5ff12b50dc5b06f60dd4e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34275308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alušík, Štefan</creatorcontrib><title>Giant cell arteritis: controversial issues</title><title>Vnitřní lékar̆stvĭ</title><addtitle>Vnitr Lek</addtitle><description>Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.</description><subject>Biopsy</subject><subject>Giant Cell Arteritis - diagnosis</subject><subject>Giant Cell Arteritis - drug therapy</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Male</subject><subject>Temporal Arteries</subject><issn>0042-773X</issn><issn>1801-7592</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LAzEQhoMottQevcoeRdg6-d54E9EqFLz04C1k8wGR7W5NtgX_vamtzuWF4eGd4UHoGsOCCqLgft93CwIEL4DLMzTFDeBackXO0RSAkVpK-jFB85w_oYxQgku4RBPKiOQUmim6W0bTj5X1XVeZNPoUx5gfKjv0Yxr2PuVouirmvPP5Cl0E02U_P-UMrV-e10-v9ep9-fb0uKqtYk0dgIjGYiWZdcYoHBg2zgQrFZQNZkq1nGJDwPEQMGk5OMtbEEGAc8wzOkO3x9ptGr7K2VFvYj78Z3o_7LImnFPCBAMoaH1EbRpyTj7obYobk741Bv0rSBdB-iBIF0GFvzlV79qNd__0nw76Ax--YEg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Alušík, Štefan</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210701</creationdate><title>Giant cell arteritis: controversial issues</title><author>Alušík, Štefan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c948-f0268c1974cdaa91f41adafc7904cd1499b531a20d5ff12b50dc5b06f60dd4e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>cze ; eng</language><creationdate>2021</creationdate><topic>Biopsy</topic><topic>Giant Cell Arteritis - diagnosis</topic><topic>Giant Cell Arteritis - drug therapy</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Male</topic><topic>Temporal Arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alušík, Štefan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Vnitřní lékar̆stvĭ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alušík, Štefan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Giant cell arteritis: controversial issues</atitle><jtitle>Vnitřní lékar̆stvĭ</jtitle><addtitle>Vnitr Lek</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>67</volume><issue>4</issue><spage>224</spage><epage>229</epage><pages>224-229</pages><issn>0042-773X</issn><eissn>1801-7592</eissn><abstract>Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.</abstract><cop>Czech Republic</cop><pmid>34275308</pmid><doi>10.36290/vnl.2021.057</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0042-773X |
ispartof | Vnitřní lékar̆stvĭ, 2021-07, Vol.67 (4), p.224-229 |
issn | 0042-773X 1801-7592 |
language | cze ; eng |
recordid | cdi_proquest_miscellaneous_2553246400 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Biopsy Giant Cell Arteritis - diagnosis Giant Cell Arteritis - drug therapy Glucocorticoids - therapeutic use Humans Inflammation Male Temporal Arteries |
title | Giant cell arteritis: controversial issues |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A59%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Giant%20cell%20arteritis:%20controversial%20issues&rft.jtitle=Vnit%C5%99n%C3%AD%20l%C3%A9kar%CC%86stv%C4%AD&rft.au=Alu%C5%A1%C3%ADk,%20%C5%A0tefan&rft.date=2021-07-01&rft.volume=67&rft.issue=4&rft.spage=224&rft.epage=229&rft.pages=224-229&rft.issn=0042-773X&rft.eissn=1801-7592&rft_id=info:doi/10.36290/vnl.2021.057&rft_dat=%3Cproquest_cross%3E2553246400%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2553246400&rft_id=info:pmid/34275308&rfr_iscdi=true |